PT1621077E - Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de um tumor do sistema nervoso central - Google Patents

Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de um tumor do sistema nervoso central Download PDF

Info

Publication number
PT1621077E
PT1621077E PT05077338T PT05077338T PT1621077E PT 1621077 E PT1621077 E PT 1621077E PT 05077338 T PT05077338 T PT 05077338T PT 05077338 T PT05077338 T PT 05077338T PT 1621077 E PT1621077 E PT 1621077E
Authority
PT
Portugal
Prior art keywords
tumor
treatment
arsenic trioxide
nervous system
central nervous
Prior art date
Application number
PT05077338T
Other languages
English (en)
Inventor
Ralph M Ellison
Fred H Mermelstein
Original Assignee
Polarx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polarx Biopharmaceuticals Inc filed Critical Polarx Biopharmaceuticals Inc
Publication of PT1621077E publication Critical patent/PT1621077E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
PT05077338T 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de um tumor do sistema nervoso central PT1621077E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6237597P 1997-10-15 1997-10-15

Publications (1)

Publication Number Publication Date
PT1621077E true PT1621077E (pt) 2008-11-04

Family

ID=22042073

Family Applications (4)

Application Number Title Priority Date Filing Date
PT08016665T PT2018858E (pt) 1997-10-15 1998-10-15 Composições e métodos para o tratamento de doenças neoplásicas primárias e metastáticas usando compostos de arsénio
PT03019628T PT1391206E (pt) 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de linfoma não-hodgkin
PT05077338T PT1621077E (pt) 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de um tumor do sistema nervoso central
PT03019594T PT1378240E (pt) 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de mieloma múltiplo

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT08016665T PT2018858E (pt) 1997-10-15 1998-10-15 Composições e métodos para o tratamento de doenças neoplásicas primárias e metastáticas usando compostos de arsénio
PT03019628T PT1391206E (pt) 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de linfoma não-hodgkin

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT03019594T PT1378240E (pt) 1997-10-15 1998-10-15 Composições farmacêuticas compreendendo trióxido de arsénico para o tratamento de mieloma múltiplo

Country Status (21)

Country Link
US (9) US6875451B2 (pt)
EP (9) EP2018858B1 (pt)
JP (1) JP2001519366A (pt)
KR (1) KR20010015755A (pt)
CN (1) CN1282218A (pt)
AT (4) ATE409043T1 (pt)
AU (1) AU751932B2 (pt)
BR (1) BR9813085A (pt)
CA (1) CA2307208A1 (pt)
CY (4) CY1108363T1 (pt)
DE (4) DE69840006D1 (pt)
DK (4) DK2018858T3 (pt)
ES (4) ES2312701T3 (pt)
HK (3) HK1061199A1 (pt)
IL (1) IL135620A0 (pt)
NO (1) NO20001977L (pt)
NZ (1) NZ503973A (pt)
PL (1) PL339909A1 (pt)
PT (4) PT2018858E (pt)
TR (1) TR200001959T2 (pt)
WO (1) WO1999018798A1 (pt)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2255800E (pt) * 1997-11-10 2012-12-17 Sloan Kettering Inst Cancer Trióxido de arsénio para uso no tratamento de leucemia
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies
DE10196619D2 (en) * 2001-07-05 2004-05-06 Hans-Werner Luedke Nahrungsergänzungsprodukt oder arzneimittel gegen bestimmte mangelzustände und hirnfunktionsstörungen
AUPR874601A0 (en) 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
KR20030058019A (ko) * 2001-12-29 2003-07-07 한국원자력연구소 삼산화비소(Ａｓ₂Ｏ₃)를 유효 성분으로 포함하는 방사선치료증진제
AU2003207455B2 (en) * 2002-01-07 2007-09-20 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
ES2425418T3 (es) * 2002-04-10 2013-10-15 Komipharm International Co., Ltd. Composición farmacéutica que comprende arsenito para el tratamiento de neoplasias
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
KR100492940B1 (ko) * 2002-05-27 2005-06-02 김종배 항종양활성 증진용 조성물
US8906422B2 (en) * 2002-10-09 2014-12-09 The University Of Hong Kong Method for inhibiting cancer using arsenic trioxide
US20080089949A1 (en) * 2006-10-13 2008-04-17 Yok-Lam Kwong Method for treating cancer using oral arsenic trioxide
US7521071B2 (en) * 2002-10-09 2009-04-21 Versitech Limited Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
US20080166425A1 (en) * 2002-10-09 2008-07-10 The University Of Hong Kong Method for inhibiting cancer using arsenic trioxide
EP2088206B1 (en) 2002-11-07 2013-07-03 Newsouth Innovations Pty Limited Induction of the mitochondrial permeability transition
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005062810A2 (en) * 2003-12-18 2005-07-14 Mediscovery, Llc Treatment of primary and metastatic neoplastic diseases with tetraarsenic decaoxide
MXPA06010043A (es) * 2004-03-01 2007-03-07 Peptimmune Inc Metodos y composiciones para el tratamiento de enfermedades autoinmunologicas.
US20050196464A1 (en) * 2004-03-03 2005-09-08 Tty Biopharm Company Limited Method and pharmaceutical composition for treatment of skin neoplasm
US20050208149A1 (en) * 2004-03-18 2005-09-22 Tty Biopharm Limited Company Use of arsenic-containing pharmaceutical composition in combination with radiation therapy for cancer treatment
US7655221B2 (en) * 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
US20060194725A1 (en) * 2004-05-07 2006-08-31 James Rasmussen Methods of treating disease with random copolymers
AU2005257982B8 (en) 2004-06-16 2011-03-10 Jack Arbiser Carbazole formulations for the treatment of psoriasis and angiogenesis
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
US20070292478A1 (en) * 2004-08-30 2007-12-20 Popowski Youri Medical Implant Provided with Inhibitors of Atp Synthesis
US8258181B2 (en) * 2005-03-23 2012-09-04 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
EP2394702B1 (en) * 2005-07-29 2014-12-31 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
US20110020434A1 (en) * 2005-09-02 2011-01-27 O'halloran Thomas V Nanoparticle arsenic-platinum compositions
US8246983B2 (en) * 2005-09-02 2012-08-21 Northwestern University Encapsulated arsenic drugs
US8784899B2 (en) * 2005-10-04 2014-07-22 Samuel Waxman Cancer Research Foundation Compositions and methods for cancer treatment
US20080233207A1 (en) * 2006-01-04 2008-09-25 Sheptovitsky Yelena G Injectable and Infusable Mercury Compositions and Methods for Treating Cancer
ITMI20060480A1 (it) * 2006-03-16 2007-09-17 Solvay Solexis Spa Usom di perfluoropolimeri nella dtermibnazione della costante di legame recettore-ligando
US20090018142A9 (en) * 2006-05-02 2009-01-15 Zhengping Zhuang Use of phosphatases to treat tumors overexpressing N-CoR
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
WO2008046299A1 (en) * 2006-10-11 2008-04-24 The University Of Hong Kong Method for inhibiting cancer using arsenic trioxide
US8268883B2 (en) 2006-11-01 2012-09-18 Newsouth Innovations Pty Limited Organo-arsenoxide compounds and use thereof
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
BRPI0806365B8 (pt) 2007-02-06 2021-05-25 Lixte Biotechnology Holdings Inc composto, uso do composto, composição farmacêutica e uso da composição farmacêutica
US20090035292A1 (en) * 2007-08-03 2009-02-05 Kovach John S Use of phosphatases to treat neuroblastomas and medulloblastomas
CN101854804B (zh) * 2007-10-01 2014-07-23 利克斯特生物技术公司 Hdac抑制剂
KR20100100835A (ko) * 2007-11-02 2010-09-15 지오팜 온콜로지 인코포레이티드 유기 비소제와의 병용 요법
JP5600597B2 (ja) * 2007-12-12 2014-10-01 ジオファーム オンコロジー， インコーポレイテッド 癌を処置するための化合物および方法
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
AU2009277179A1 (en) * 2008-08-01 2010-02-04 Lixte Biotechnology, Inc. Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
US8227473B2 (en) 2008-08-01 2012-07-24 Lixte Biotechnology, Inc. Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
US8058268B2 (en) * 2008-08-01 2011-11-15 Lixte Biotechnology, Inc. Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
MX2011001800A (es) 2008-08-20 2011-04-04 Ziopharm Oncology Inc Compuestos de arsenico organico y metodos para el tratamiento de cancer.
KR101100786B1 (ko) * 2008-12-16 2011-12-29 (주)천지산 암에 대한 방사선 치료 증진용 조성물
TR201905548T4 (tr) * 2009-09-10 2019-05-21 Kominox Inc Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi.
BR112012008310A2 (pt) * 2009-09-18 2017-06-06 Kominox Inc métodos para tratamento de tumores cerebrais
US20120015023A1 (en) * 2010-04-15 2012-01-19 Antimisiaris Sophia G Treatment of tumors prostate with arsonoliposomes
WO2014151317A1 (en) * 2013-03-15 2014-09-25 Rush University Medical Center Methods for treating cancer
WO2014152330A1 (en) * 2013-03-15 2014-09-25 Stc.Unm Arsenic-based treatment of cancers and inflammatory disorders
CN105209036B (zh) 2013-04-09 2018-10-26 莱克斯特生物技术公司 氧杂双环庚烷和氧杂双环庚烯的配制品
FR3004949B1 (fr) * 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
US9700580B1 (en) 2016-06-14 2017-07-11 Marguerite Harning Method for cancer treatment
PE20191544A1 (es) 2016-12-01 2019-10-24 Eupharma Pty Ltd Composiciones de arsenico
KR101844050B1 (ko) * 2016-12-09 2018-05-14 주식회사 케마스 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
WO2018209343A1 (en) * 2017-05-12 2018-11-15 Rajur Sharanappa Basappa Novel methods, compounds, and compositions: small molecule anticancer agents
WO2019234112A1 (en) 2018-06-05 2019-12-12 Katholieke Universiteit Leuven Combination treatment of arsenic oxide and antiandrogens
CN112675197A (zh) * 2021-01-22 2021-04-20 中山大学孙逸仙纪念医院 一种用于儿童Hedgehog信号通路驱动肿瘤的药物组合物
CN114028425A (zh) * 2021-09-24 2022-02-11 上海交通大学医学院附属新华医院 硫化砷及其与放疗联合在治疗横纹肌肉瘤上的应用
CN115634287A (zh) * 2022-09-30 2023-01-24 苏州系统医学研究所 一种基于砷化合物的肿瘤疫苗及其制备方法和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132275A (en) 1872-10-15 Improvement in medical compounds
US232807A (en) 1880-10-05 Herbert e
US3700498A (en) 1970-12-10 1972-10-24 Ibm Process for making electrophotographic plates
JPS5188620A (en) 1975-01-31 1976-08-03 Jintainokenkonoiji kotonigannitaishitekonoojusuru noshukuionekinoseizoho
DE3003635C2 (de) 1980-02-01 1985-07-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Verfahren und Vorrichtung zur Entarsenierung arsenhaltiger Materialien
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
NL8502929A (nl) * 1985-10-25 1987-05-18 Tno Groep viii-overgangsmetaal-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke groep viii-overgangsmetaal-complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.
US5759837A (en) 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
CN1061908A (zh) 1991-12-21 1992-06-17 江西省妇产医院 一种治癌药物的制造方法
CN1060935C (zh) 1992-05-31 2001-01-24 丛繁滋 用于癌病灶直接给药的砷制剂的制备方法
CN1044777C (zh) 1992-07-06 1999-08-25 杨世泽 癌痛止痛膏的配制方法
DK0651636T3 (da) 1992-07-24 2003-01-27 Univ Johns Hopkins Kemoterapi for cancer
FR2699820B3 (fr) * 1992-12-24 1995-03-10 Eric Pichot Traitement homéopathique préventif des dysmytoses (cancer, leucémie) et malformations ou mutations génétiques.
DE4317331A1 (de) * 1993-05-25 1994-12-01 Reischle Karl Georg Behandlung von Schädigungen des Immunsystems
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
WO1995022336A1 (fr) 1994-02-18 1995-08-24 Tamara Vasilievna Vorobieva Agent immunomodulateur et reducteur du dysfonctionnement du systeme de regulation de la propagation de cellules tissulaires
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
CN1119113A (zh) 1994-09-22 1996-03-27 衣永德 复方癌复康胶囊及制备方法
CN1122700A (zh) 1994-11-08 1996-05-22 付知中 一种治疗乳腺疾病、肿瘤疮毒的散剂及其制备方法
LV11667B (en) * 1995-08-14 1997-06-20 Tamara Vorobieva Remedy for renewal of disordered function of immunomodulation and cell tissue reproduction adjustors
CN1044559C (zh) 1995-08-23 1999-08-11 哈尔滨医科大学附属第一医院 抗白血病、肝癌、淋巴瘤注射液
US5748699A (en) * 1995-10-06 1998-05-05 Smith; Donald O. Apparatus for applying X-rays to an interior surface of a body cavity
CN1058620C (zh) 1995-11-12 2000-11-22 卢颖 一种治疗癌症的外用中成药及配备生产工艺
CN1052648C (zh) 1995-12-03 2000-05-24 唐书生 癌瘤消肿止痛膏
PT2255800E (pt) 1997-11-10 2012-12-17 Sloan Kettering Inst Cancer Trióxido de arsénio para uso no tratamento de leucemia
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
DE60313344T2 (de) * 2002-09-24 2008-01-03 Novartis Ag Verwendung von 4-pyridylmethyl-phthalazin-derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen
US20050196464A1 (en) * 2004-03-03 2005-09-08 Tty Biopharm Company Limited Method and pharmaceutical composition for treatment of skin neoplasm

Also Published As

Publication number Publication date
PL339909A1 (en) 2001-01-15
CN1282218A (zh) 2001-01-31
KR20010015755A (ko) 2001-02-26
US7205001B2 (en) 2007-04-17
CY1108363T1 (el) 2014-02-12
EP1374875A3 (en) 2004-01-07
EP1621077A1 (en) 2006-02-01
WO1999018798A1 (en) 1999-04-22
CY1110057T1 (el) 2015-01-14
US7132116B2 (en) 2006-11-07
ATE399560T1 (de) 2008-07-15
TR200001959T2 (tr) 2000-11-21
EP1419778A1 (en) 2004-05-19
BR9813085A (pt) 2000-08-22
ATE493979T1 (de) 2011-01-15
EP2018858B1 (en) 2011-01-05
EP1391206B1 (en) 2008-07-02
US20040047916A1 (en) 2004-03-11
IL135620A0 (en) 2001-05-20
EP1022951A1 (en) 2000-08-02
CY1110055T1 (el) 2015-01-14
CY1111379T1 (el) 2015-08-05
DE69840057D1 (de) 2008-11-06
JP2001519366A (ja) 2001-10-23
EP1466607A1 (en) 2004-10-13
EP2018858A1 (en) 2009-01-28
US20040161475A1 (en) 2004-08-19
DK2018858T3 (da) 2013-01-07
US20050100611A1 (en) 2005-05-12
ES2309258T3 (es) 2008-12-16
AU1089399A (en) 1999-05-03
ES2313201T3 (es) 2009-03-01
US20040197420A1 (en) 2004-10-07
DK1621077T3 (da) 2009-01-26
US20040096518A1 (en) 2004-05-20
HK1061199A1 (en) 2004-09-10
ATE409043T1 (de) 2008-10-15
ATE407683T1 (de) 2008-09-15
PT2018858E (pt) 2011-03-24
PT1378240E (pt) 2008-11-14
US20020183385A1 (en) 2002-12-05
EP1378241A1 (en) 2004-01-07
EP1378240B1 (en) 2008-09-10
DE69839682D1 (de) 2008-08-14
EP1378240A3 (en) 2004-01-14
US7163703B2 (en) 2007-01-16
EP1022951A4 (en) 2002-06-19
DK1391206T3 (da) 2008-09-01
NO20001977L (no) 2000-06-13
AU751932B2 (en) 2002-08-29
DE69842094D1 (de) 2011-02-17
EP1391206A1 (en) 2004-02-25
PT1391206E (pt) 2008-08-13
US20040197421A1 (en) 2004-10-07
EP1374875A2 (en) 2004-01-02
US6875451B2 (en) 2005-04-05
HK1085886A1 (en) 2006-09-08
DE69840006D1 (de) 2008-10-23
ES2312701T3 (es) 2009-03-01
US20050191367A1 (en) 2005-09-01
NZ503973A (en) 2001-09-28
ES2358624T3 (es) 2011-05-12
EP1378240A2 (en) 2004-01-07
EP1621077B1 (en) 2008-09-24
CA2307208A1 (en) 1999-04-22
US20040115283A1 (en) 2004-06-17
NO20001977D0 (no) 2000-04-14
HK1061198A1 (en) 2004-09-10
US7179493B2 (en) 2007-02-20
DK1378240T3 (da) 2008-12-08

Similar Documents

Publication Publication Date Title
HK1085886A1 (en) Phamaceutical compositions comprising arsenic trioxide for the treatment of a tumor of the central nervous system
IL150767A (en) Benzophyrene compounds and their use in the manufacture of drugs for the treatment of estrogen-sensitive diseases such as endometrial cancer
MXPA01013395A (es) Tratamiento de cancer de prostata con anticuerpos anti-erbb2.
PT1187632E (pt) Tratamento com anticorpos anti-erbb2
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
WO1997047296A3 (en) Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
ZA200202822B (en) Oncolytic combinations for the treatment of cancer.
WO2001082871A3 (en) Method of using zinc isotope for therapy and diagnosis of colon cancer
BR0215689A (pt) Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
AU5302599A (en) Method for diagnosing bone metastasis of malignant tumor
IL160382A0 (en) Use of 4-pyridylmethylphthalazines for cancer treatment
CA2294243A1 (en) Novel cyanoaziridines for treating cancer
MXPA04002407A (es) Uso de 4-piridilmeetil-ftalazinas para el tratamiento de cancer.
ZA9811598B (en) A substance or composition for the treatment of cancer.